The Department of Pediatric Hemato-Oncology at the Queen Fabiola Children's University Hospital (HUDERF) is recruiting a Hemato-Oncology Clinical Studies Coordinator (CDI - 38H).
In October 2023, a new registry (RELIVE) was open in Belgium.
In September 2023, ALCL-VBL trial was launched to evaluate Vinblastine treatment for children under 18 with Anaplastic Large Cell Lymphoma.
New booklet by BAYER: 'Detective Didi & Sidekick' - Helping Kids Understand Cancer.
September is the month to raise awareness and support for young cancer patients and their families. Learn more about childhood cancer.
New study launched: FaR-RMS study investigates novel treatments for pediatric and adult Rhabdomyosarcoma patients, aiming to enhance outcomes.
The Belgian Cancer Registry presents its latest publication 'Cancer in children and adolescents in Belgium 2004-2020'.
Update for healthcare professionals: Teva Pharma Belgium introduces new indications and reimbursement criteria for LONQUEX® (lipegfilgrastim) 6 mg, effective from 1 March 2023.
The SIOPE ATRT01 trial launched in August 2024, aims to improve treatment efficacy and neurocognitive outcomes for children with Atypical Teratoid/Rhabdoid Tumours (ATRT).
.png?width=3072&format=webp)
The ML-DS 2018 trial aims to improve outcomes for Down syndrome patients with myeloid leukemia (ML) or myelodysplastic syndrome (MDS).
.png?width=3072&format=webp)
The Symposium on 22 November featured key insights into novel therapies and new techniques in pediatric oncology. See topics discussed and event photos.
PRINCESS, a multicentre clinical trial open since 9 October 2024 in Belgium, aims to assess fertility and ovarian function in survivors of childhood cancer aged 18 years or older.
BSPHO's new vision focuses on research support, clinical trials, advocacy, outreach, and greater member involvement in pediatric cancer care.
BSPHO awards up to 1,100€ scholarships to young doctors/researchers. See eligibility and application details below.
A new trial for infants (<1 year) with KMT2A‐rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia launched in Belgium.
The BSPHO Scientific Meeting on 20 September featured key insights into pediatric haemato-oncology research. See topics discussed and event photos.
The CAYA policy brief publication outlines key recommendations to improve care and outcomes for young cancer patients.
.png?width=3072&format=webp)
BSPHO coordinated the care of the young gazan patients from Gaza by paediatric oncology centres across the country.
The BSPHO Clinical Trial Day 2024 was held on 21 June at the Park Inn Hotel in Leuven. Read the event highlights.
In June 2024, the International Euro Ewing (iEuroEwing) trial was launched to evaluate treatment optimisation in patients with Ewing sarcoma.
In January 2024, the NORDIC trial launched and will evaluate Cerebellar Mutism Syndrome in children undergoing brain tumour surgery.
In September 2023, ALCL-VBL trial was launched to evaluate Vinblastine treatment for children under 18 with Anaplastic Large Cell Lymphoma.
New booklet by BAYER: 'Detective Didi & Sidekick' - Helping Kids Understand Cancer.
New study launched: FaR-RMS study investigates novel treatments for pediatric and adult Rhabdomyosarcoma patients, aiming to enhance outcomes.
The Belgian Cancer Registry presents its latest publication 'Cancer in children and adolescents in Belgium 2004-2020'.
We are pleased to share Neuroblastoma educational materials developed by the working groups (WG) for patients and their families. Learn more about it and find the material here!
BSPHO coordinated the arrival of 4 Ukrainian children with cancer in Belgium to ensure the best care for patients and their families.